This compound is a pharmaceutical intermediate featuring a complex polycyclic structure with multiple amide and ether functional groups. It is structurally characterized by a tetracyclic core containing a methoxy group and a trifluorophenylmethyl substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Bictegravir
pharmaceutical raw material
Bictegravir sodium
pharmaceutical raw material
(1S,11R,13R)-5-methoxy-3,6-dioxo-12-oxa-2,9-diazatetracyclo[11.2.1.02,11.04,9]hexadeca-4,7-diene-7-carboxylic acid
pharmaceutical intermediate
3-(3,4-difluorophenyl)propanoyl chloride
pharmaceutical intermediate
5,6-Difluoroindanone
pharmaceutical intermediate
21-hydroxy triamcinolone acetonide
pharmaceutical intermediate
(1S,11R,13R)-5-methoxy-3,6-dioxo-N-[(2,4,6-trifluorophenyl)methyl]-12-oxa-2,9-diazatetracyclo[11.2.1.02,11.04,9]hexadeca-4,7-diene-7-carboxamide
GCAOXZIBYQSMMA-XWCIJXRUSA-N
COC1=C2C(=O)N3[C@H]4CC[C@H](C4)O[C@@H]3CN2C=C(C1=O)C(=O)NCC5=C(C=C(C=C5F)F)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.